This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Proven in more clinical studies than any other single-injection hyaluronic acid knee therapy, DUROLANE has been shown to be safe and effective.
During the DUROLANE pivotal trial:17
- No serious adverse events were considered related to DUROLANE treatment.17
- The most common adverse events were arthralgia (8.6%), injection site pain (2.3%), and joint swelling (1.7%).17
DUROLANE is safe for repeated courses of therapy. Repeat administration of a course of DUROLANE therapy does not increase the incidence of adverse events.10,17
Choose DUROLANE for Longer-lasting Results
- Increased residence time in the knee joint ‡27,29-32
- A half-life of 4 weeks in the knee joint, in both animals and humans.16,29
- The longest reported half-life of any hyaluronic acid product.29-32
‡The clinical relevance of this information has not been determined.